|
Title
|
Published
|
Price
|
|
Oxygen Therapy
By: Global Industry Analysts
The global outlook series on Oxygen Therapy provides statistical anecdotes, market briefs, and concise summaries of research findings. The report offers an aerial view of the global oxygen therapy industry, identifies major short to medium
|
more...
|
10/1/2009
|
$950.00
|
|
Infections Tuberculosis Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Tuberculosis Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of tuberculosis drugs by company and by stage as well as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Cancer Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Respiratory and Pulmonary System Chronic Obstructive Pulmonary Disease Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Chronic Obstructive Pulmonary Disease Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of chronic obstructive pulmonary disease drugs by company
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Respiratory and Pulmonary System Respiratory Tract Infections Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Respiratory Tract Infections Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of respiratory tract infections drugs by company and by
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Respiratory and Pulmonary System Pulmonary Hypertension Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Pulmonary Hypertension Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of pulmonary hypertension drugs by company and by stage as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Respiratory and Pulmonary System Pulmonary Fibrosis Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Pulmonary Fibrosis Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of pulmonary fibrosis drugs by company and by stage as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Respiratory and Pulmonary System Nasal congestion Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Nasal congestion Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of nasal congestion drugs by company and by stage as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Respiratory and Pulmonary System Cystic Fibrosis Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Cystic Fibrosis Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of cystic fibrosis drugs by company and by stage as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Respiratory and Pulmonary System Cough Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Cough Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of cough drugs by company and by stage as well as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Respiratory and Pulmonary System Bronchospasm Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Bronchospasm Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of bronchospasm drugs by company and by stage as well as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Respiratory and Pulmonary System Bronchitis Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Bronchitis Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of bronchitis drugs by company and by stage as well as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Respiratory and Pulmonary System Asthma Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Asthma Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of asthma drugs by company and by stage as well as
|
more...
Search inside this report
|
9/14/2009
|
$1,495.00
|
|
Chinese Markets for Respiratory Drugs
By: Asia Market Information & Development Company
China's demand for Respiratory Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends,
|
more...
Search inside this report
|
9/1/2009
|
$4,000.00
|
|
Competitive Outlook on Lung Cancer Drug Development - The Missing Handbook to New Product Planning and Portfolio Planning
By: BioSeeker Group AB
This report includes defined and up to date development strategies for 283 lung cancer therapeutic drugs (>317 projects) within the portfolio of 167 investigators, from Ceased to Marketed. In total the report assesses three different
|
more...
|
8/25/2009
|
$3,500.00
|
|
World Respiratory Disorders Market 2009-2024
By: Visiongain
Respiratory disorder therapies form an important and competitive part of the pharmaceutical market worldwide. There are wide ranges of drugs and therapeutic needs, both acute and chronic. Revenues are high currently, with good potential for
|
more...
|
6/23/2009
|
$2,502.00
|
|
The 2009 Report on Pulmonary Drug Delivery Systems: World Market Segmentation by City
By: Icon Group International, Inc.
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets,
|
more...
Search inside this report
|
5/1/2009
|
$795.00
|
|
Chronic Obstructive Pulmonary Disease (COPD) Market: An Analysis
By: Koncept Analytics
In the present era, use of tobacco, polluted environment, poverty and aging population have become a major threat; all these factors account for a major cause of deaths by COPD. Market for COPD medication is
|
more...
Search inside this report
|
5/1/2009
|
$800.00
|
|
The 2009 Report on Respiratory and Cerebral Central Nervous System Stimulants Excluding Non-Drug Dietaries for Weight Control: World Market Segmentation by City
By: Icon Group International, Inc.
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets,
|
more...
Search inside this report
|
5/1/2009
|
$795.00
|
|
Chinese Markets for Cough Drugs
By: Asia Market Information & Development Company
China's demand for Cough Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic
|
more...
Search inside this report
|
4/1/2009
|
$4,000.00
|
|
Stakeholder Opinions: Tuberculosis - Development pipeline shows signs of life
By: Datamonitor
Introduction Tuberculosis is a major cause of illness and death worldwide, but despite 14.4 million prevalent cases, 9.2 million new cases and 1.7 million deaths in 2006, the small and rapidly declining burden of disease in
|
more...
|
3/20/2009
|
$3,800.00
|
|
Respiratory Tract Infections Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Respiratory Tract Infections Therapy Area Pipeline Report contains detailed information on the respiratory tract infections drug pipeline. This report provides insight into the pipeline status of respiratory tract infections drugs by company
|
more...
Search inside this report
|
3/16/2009
|
$1,495.00
|
|
Cystic Fibrosis Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Cystic Fibrosis Therapy Area Pipeline Report contains detailed information on the cystic fibrosis drug pipeline. This report provides insight into the pipeline status of cystic fibrosis drugs by company and by stage
|
more...
Search inside this report
|
3/16/2009
|
$1,495.00
|
|
Cough Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Cough Therapy Area Pipeline Report contains detailed information on the cough drug pipeline. This report provides insight into the pipeline status of cough drugs by company and by stage as well as
|
more...
Search inside this report
|
3/16/2009
|
$1,495.00
|
|
Bronchitis Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Bronchitis Therapy Area Pipeline Report contains detailed information on the bronchitis drug pipeline. This report provides insight into the pipeline status of bronchitis drugs by company and by stage as well as
|
more...
Search inside this report
|
3/16/2009
|
$1,495.00
|
|
Title
|
Published
|
Price
|
(0 items)
